Azul (NYSE:AZUL) Q4 2025 Earnings call March 27, 2026 10:00 AM ET Speaker5Azul's fourth quarter earnings conference call. My name is Zach, and I will be your operator for today. This event is being recorded, and all participants will be in listen-only mode until we conduct a Q&A session following the company's presentation. If you have a question, click on the Q&A icon at the bottom of your screen and write your name and company. When your name is announced, please turn your microphone on and proceed. For t ...

This presentation includes estimates and forward-looking statements within the meaning of US federal securities laws. These estimates and forward-looking statements are based mainly on our current expectations and estimates of future events and trends that affect or may affect our business, financial condition, results of operations, cash flow, liquidity, and the trading price of our preferred shares, including in the form of ADSs. Although we believe these estimates and forward-looking statements are based ...

Achieves Record First Quarter Operating Results and Record Bookings Introduces PROPEL, Ambitious Targets Designed to Reflect Continued Earnings Growth Momentum Through 2029 First Quarter 2026 Earnings Presentation 1 Disclaimers, Forward Looking Statements and Responsibility Because forward-looking statements involve risks and uncertainties, there are many factors that could cause our actual results, performance or achievements to differ materially from those expressed or implied by our forward-looking state ...

DISCLAIMER REGARDING FORWARD-LOOKING STATEMENTS This presentation may contain forward-looking statements. These statements are not historical facts and are based on the Company's current vision and estimates of the Company's management regarding future economic and other circumstances, industry conditions, performance and financial results, including any potential or projected impact related to Alagoas and related legal proceedings on the Company's business, financial condition and operating results. The wo ...

Rocket Pharmaceuticals (NasdaqGM:RCKT) FDA announcement March 27, 2026 08:30 AM ET Company ParticipantsAndrew Tsai - Managing DirectorGaurav Shah - CEOJason Zemansky - VP of Equity ResearchJonathan Schwartz - Chief Science and Gene Therapy OfficerMeg Dodge - Senior VP of External AffairsMichael Ulz - Executive Director of Biotechnology Equity ResearchSarbani Chaudhuri - Chief Commercial OfficerYun Zhong - Senior VP of Biotechnology Equity ResearchConference Call ParticipantsJosh Schimmer - Biotech Equity Re ...

Nortech Systems (NasdaqCM:NSYS) Q4 2025 Earnings call March 27, 2026 08:30 AM ET Company ParticipantsAndrew D. C. LaFrence - CFO and SVP of FinanceJay D. Miller - President and CEOOperatorGood morning, ladies and gentlemen, and welcome to the Nortech Systems Incorporated fourth quarter 2025 earnings conference call. With me on the line today are Mr. Jay Miller, President and Chief Executive Officer, and Andrew LaFrence, Chief Financial Officer and Senior Vice President of Finance. All lines have been placed ...

Sanuwave Health (NasdaqGM:SNWV) Q4 2025 Earnings call March 27, 2026 08:30 AM ET Company ParticipantsAlbert Hanser - Founder and CEOEthan Starr - Private InvestorIan Cassel - Founder and Chief Investment OfficerMorgan Frank - CEO and Chairman of the BoardPeter Sorensen - CFOConference Call ParticipantsCarl Byrnes - Senior Equity Research AnalystKyle Bowser - Senior Research AnalystOperatorHello and welcome everyone joining today's Sanuwave earnings call. At this time, all participants are in a listen only m ...

Super League Gaming (NasdaqCM:SLE) Q4 2025 Earnings call March 27, 2026 08:30 AM ET Company ParticipantsJames Kisner - Managing Director of TechnologyMatt Edelman - President and CEORommel Dionisio - Head of ResearchConference Call ParticipantsJack Vander Aarde - VP and Senior Research AnalystOperatorGreetings, and welcome to the Super League fourth quarter and full year 2025 conference call. Please note this conference is being recorded. Before we begin, I'd like to caution listeners that comments made by ...

Autolus Therapeutics (NasdaqGS:AUTL) Q4 2025 Earnings call March 27, 2026 08:30 AM ET Company ParticipantsAmanda Cray - Executive Director of Investor RelationsChristian Itin - CEOEmily Bodnar - VP of Equity ResearchJames Shin - Director of Biopharma Equity ResearchMatt Phipps - Partner and Group Head of Biotechnology Equity ResearchRob Dolski - CFOSalim Syed - Managing DirectorConference Call ParticipantsGil Blum - Senior AnalystYanan Zhu - Senior Biotech AnalystNone - AnalystOperatorGood day and thank you ...

Kopin (NasdaqCM:KOPN) Q4 2025 Earnings call March 27, 2026 08:30 AM ET Company ParticipantsAustin Moeller - Director of Equity ResearchErich Manz - CFOJaeson Schmidt - Director of ResearchJonathan Siegmann - Managing DirectorMichael Murray - CEOConference Call ParticipantsChristian Schwab - Senior Research AnalystOperatorGood morning, everyone, and welcome to the Kopin Corporation Fourth Quarter 2025 Earnings Conference Call. During today's presentation, all parties will be in a listen-only mode. Following ...